Nanosphere's FY 2010 Revenues Drop 9 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market Wednesday that its full-year 2010 revenues declined 9 percent to $2 million from $2.2 million.

The Northbrook, Ill.-based molecular diagnostics developer fell short of analysts' consensus estimate of $2.4 million in revenues for the year.

Its product sales increased to $1.4 million from $1.1 million year over year, while its grant and contract revenue fell to $610,000 from $1.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.